BEAM vs TGB Comparison

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.